Caspases and programmed cell death in sepsis: mechanisms, pathophysiology, and therapeutic targets. [PDF]
He H +10 more
europepmc +1 more source
Mitochondrial programmed cell death in bronchopulmonary dysplasia: mechanisms and therapeutic targets. [PDF]
Jiang J, Wang M, Yao H, Zhu Y, Lu H.
europepmc +1 more source
Immune-programmed cell death crosstalk implicates plasma sTNFR1 as a candidate biomarker for sepsis-associated encephalopathy. [PDF]
Wang C +8 more
europepmc +1 more source
Survival Impact of Programmed Cell Death Ligand-1 Expression in Patients With Epithelial Ovarian Carcinoma. [PDF]
Tankul A +8 more
europepmc +1 more source
Correction: Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes. [PDF]
Luo F +7 more
europepmc +1 more source
Programmed cell death in metabolic syndrome: From molecular mechanisms to therapeutic strategies (Review). [PDF]
Zhong J +8 more
europepmc +1 more source
Design, synthesis and activity evaluation of tetrahydroisoquinoline-based programmed cell death ligand 1 inhibitors. [PDF]
Yu M +15 more
europepmc +1 more source
Necro-mosaic: a lesion-aware framework for testing programmed cell-death-associated mechanisms in tuberculosis. [PDF]
Zhang Q, Chang.
europepmc +1 more source
Programmed cell death in degenerative skeletal diseases: molecular crosstalk and combinatorial therapeutic strategies. [PDF]
Zhao R +6 more
europepmc +1 more source
Determinants of Senecavirus A Pathogenesis: From Viral Genome to ANTXR1, Immunity, and Programmed Cell Death. [PDF]
Zhang X +13 more
europepmc +1 more source

